Aroa posts $1.5m half year loss but forecasts up to $6m annual profit

Aroa posts $1.5m half year loss but forecasts up to $6m annual profit
Aroa develops, manufactures and distributes medical and surgical products. (Image: Supplied)
John Anthony
Soft tissue regeneration company Aroa Biosurgery has posted a $1.5 million loss for the six months to September but is forecasting annual profit of between $2m and $6m.Founded in 2008, Aroa Biosurgery is headquartered in Auckland and is listed on the Australian Securities Exchange (ASX) with a share price of A65c (NZ72c).The company, which was formerly called Mesynthes, develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction.ImprovementIts loss for the half year to...

More Markets

Rocket Lab nabs Biden funding
Markets

Rocket Lab nabs Biden funding

Rocket Lab has hit a milestone by launching two Electron rockets within 24 hours.The New Zealand-American firm also said on Tuesday it had finalised US$23.9 million (NZ$41.3m) in Biden administration “Chips Act” funding.Proposed recipients of funding under the legislation, design...

Pacific Edge posts $14.5m loss
Markets

Pacific Edge posts $14.5m loss

The cancer diagnostics company is awaiting outcomes of several events.

Blis in the black
Markets

Blis in the black

Blis has reported an increase in revenue and earnings despite a patent dispute.

Gentrack hits $213m revenue, profit dips
Markets

Gentrack hits $213m revenue, profit dips

Software firm won't pay dividend as it plans for more growth in consolidating markets.